THE US Food and Drug
Administration has revealed a
US$25m plan to be run over the
next 12 months to update its
prescription drug, device and food
safety review tools, under its
Regulatory Science Initiative.
The plan will see the agency
collaborate with industry pundits,
the government, scientists and
members of the academia to
improve its scientific standards,
which will in turn expedite
regulatory approval of new medicines.
Programs under the plan will
include research into potential
drug side effects using a patient’s
genetic code rather than animal
testing.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Oct 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Oct 10
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.